Centro de Fertilidad CDMX

The clinic holds a sanitary licence issued by the Federal Commission for the Protection against Sanitary Risks (COFEPRIS), which is responsible for regulating assisted reproduction facilities in Mexico. COFEPRIS sets minimum standards for embryology laboratory infrastructure, equipment, and staffing. The clinic is also a member of the Red Latinoamericana de Reproduccion Asistida (REDLARA), the Latin American network that audits member clinics' laboratory standards and collates outcome data. Both accreditations have been confirmed against primary sources. Patients can verify COFEPRIS status at gob.mx/cofepris and REDLARA membership at redlara.com.

Reproductive endocrinologists in Mexico must hold a cedula profesional in gynaecology and obstetrics, and a subspecialty cedula in reproductive biology or human reproduction where applicable. Both can be verified at cedulaprofesional.sep.gob.mx by entering the practitioner's full name or registration number. Patients should also ask whether the embryologist holds recognised credentials from the Red Latinoamericana de Reproduccion Asistida or the European Society of Human Reproduction and Embryology. The clinic publishes outcome data to the REDLARA international registry, which provides an additional reference point for evaluating laboratory performance.

Egg donation in Mexico is governed at the federal level by the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) through the General Health Law and associated regulations. There is no single federal statute specifically regulating third-party reproduction, and regulatory practice varies between states. In Mexico City, anonymous donation is customary and widely practised. Compensation for donors is legally ambiguous — altruistic donation is the stated framework, though donor expenses are commonly reimbursed. Patients should request a written explanation of the clinic's donor recruitment and screening protocol and confirm that donors have undergone COFEPRIS-required health and genetic screening.

Surrogacy law in Mexico is a state-by-state matter rather than a federal one. Mexico City does not have legislation that explicitly authorises surrogacy arrangements, and the legal pathway is considerably more complex than in states such as Tabasco and Sinaloa, which have historically been more permissive. Patients considering gestational surrogacy via a Mexico City clinic should obtain independent legal advice from a Mexican family lawyer before proceeding. The Federal Commission for the Protection against Sanitary Risks (COFEPRIS) regulates the clinical aspects, but parentage and citizenship documentation for any resulting child are governed by civil law in the relevant state, not by COFEPRIS.

Ovarian hyperstimulation syndrome (OHSS) is the most significant acute complication of IVF stimulation. Moderate to severe OHSS may require hospitalisation for fluid management. Patients should confirm before treatment which hospital the clinic has a transfer arrangement with and whether that hospital has obstetric and acute medicine capabilities. Patients undergoing treatment from abroad should also confirm the protocol if a complication develops after they have returned home, including which clinical records will be shared with their home-country physician and how quickly. Written emergency contact details and a 24-hour clinical line should be provided at the start of treatment.

Egg retrieval is performed under intravenous sedation or general anaesthesia, typically of short duration. Patients should confirm whether a separately qualified anaesthesiologist attends every retrieval procedure. Anaesthesiologists in Mexico must hold a cedula profesional in anaesthesiology, verifiable at cedulaprofesional.sep.gob.mx. Patients should disclose all current medications, allergies, and relevant medical history during the pre-treatment consultation, as some medications — particularly stimulants, anticoagulants, and herbal supplements — interact with agents used in sedation protocols.

The clinic publishes IVF pricing. A basic stimulated IVF cycle at fertility clinics in Mexico City has generally been quoted in the USD $3,500–$6,500 range, though the total cost depends significantly on whether donor eggs are used, the number of embryos transferred, whether preimplantation genetic testing is included, and the cost of fertility medications, which are not always included in headline prices. Patients should request a written treatment plan with an itemised cost estimate covering all foreseeable components before commencing the stimulation protocol.

A single IVF cycle does not guarantee a pregnancy, and patients should clarify the clinic's policy for subsequent cycles before beginning treatment. Relevant questions include whether any unused frozen embryos from a stimulated cycle can be used in a subsequent frozen embryo transfer, the cost of embryo storage, and whether the clinic offers any multi-cycle pricing arrangements. Patients who return to the United States or Canada between cycles should confirm how frozen embryo storage and international shipment are handled and which laboratory protocols govern the thawing process.

IVF patients who return to their home country following egg retrieval and embryo transfer require ongoing monitoring including blood tests for beta-hCG levels and, if pregnant, early obstetric ultrasound. Patients should confirm before travel whether the clinic will liaise directly with a home-country reproductive endocrinologist or obstetrician, and what documentation — including cycle summary, embryology report, and transfer details — will be provided for the treating physician abroad. The clinic offers video consultation for remote follow-up, and patients should establish the schedule for these calls before departing Mexico City.

The clinic is documented as serving international patients and publishes its pricing online, which is consistent with catering to a non-Spanish-speaking patient base. Patients should confirm whether the treating reproductive endocrinologist and embryologist conduct consultations directly in English, or whether a patient co-ordinator provides interpretation. All clinical consent forms, stimulation protocols, medication instructions, and cycle monitoring schedules should be provided in English. Medication names used in Mexico may differ from those used in the United States or Canada; patients should obtain the generic international names for all prescribed drugs.